Oluwatosin Goje, MD
Obstetrics & Gynecology · Cleveland, OHNPI 1053552844
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $65,282 of the $80,960 with a category attached, or 80.6%. Merck accounts for 64.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $32,382, 6.8 times the $4,765 reported in 2019. Among obstetrics & gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $1527.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$52K
- Biomerieux Inc$11K
- Cepheid$4K
- Modernatx, Inc.$4K
- Gen-probe Sales & Service, Inc.$4K
- Lupin Inc.$3K
- plus $2K from 3 others
Across 3 payments — averaging $4890.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Scynexis, Inc.$15K
What the payments were for
- Consulting fees$65,28281%
- Speaking & faculty fees$6,8909%
- Travel & lodging$7,0799%
- Food & beverage$1,7092%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 34 | $52,298 |
| Biomerieux Inc | 6 | $11,420 |
| Cepheid | 4 | $4,192 |
| Modernatx, Inc. | 1 | $4,000 |
| Gen-probe Sales & Service, Inc. | 1 | $3,600 |
| Lupin Inc. | 1 | $3,000 |
| Life Technologies Corporation | 1 | $1,400 |
| Scynexis, Inc. | 4 | $934 |
| AbbVie | 1 | $115 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mResvia$4,000
How this compares
$80,960 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 12 | $5,403 |
| Estradiol | 46 | $3,371 |
| Clobetasol Propionate | 35 | $2,409 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 42 | $970 |
| Metronidazole | 18 | $553 |
| Fluconazole | 48 | $519 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cleveland
- Jeffrey MangelCleveland$61K
- Julian PeskinCleveland$33K
- Shirley BennettCleveland$25K
- Robert PollardCleveland$16K
- Linda BradleyCleveland$15K
- Alexander KotlyarCleveland$13K
- Kathryn CoyneCleveland$12K
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.